Hjem › Neurofibrosarkom › New York
Neurofibrosarkom kliniske forsøg i New York
6 studier for Neurofibrosarkom søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
- New york cancer and blood specialists - Oncology, Port Jefferson Station
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05245500SPEARHEAD-3 Pediatric Study
- Memorial Sloan Kettering Kids, New York
RekruttererFase 1/2
Alder 2 til 21 · Alle køn · Opdateret 11. aug. 2026 · NCT05642455A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
- og 1 flere
RekruttererFase 2
12 Months · Alle køn · Opdateret 6. maj 2026 · NCT05985161Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
- Memorial Sloan Kettering Cancer Center, New York
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 9. mar. 2026 · NCT03141021A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- og 1 flere
RekruttererFase 2
Alder 16 og opefter · Alle køn · Opdateret 5. feb. 2026 · NCT04872543Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.